Following the deaths of 12 children in Madhya Pradesh and Rajasthan, the Tamil Nadu government has completely banned the sale of "Coldrif" cough syrup and ordered its removal from the market. The sale of cough syrup manufactured by this Chennai-based company has been banned throughout Tamil Nadu.
Meanwhile, drug control officials from Delhi and Chennai inspected the manufacturing unit at a pharmaceutical plant in Kanchipuram. The Rajasthan government has suspended the state drug controller and banned the sale of medicines manufactured by the Jaipur-based company, Kaysons Pharma.
Cough Syrup Banned
The Tamil Nadu government has banned the sale of the cough syrup "Coldrif" and issued an order to remove it from the market. The Food Safety Department stated that its production and sale are completely banned in the state from October 1st. The production plant in the Kanchipuram district was inspected, and samples were collected. The company has been banned from producing the syrup until the test results are received from a government lab.
It is noteworthy that the pharmaceutical company, located in Sunguvarachatram, Kanchipuram district, supplies medicines to Rajasthan, Madhya Pradesh, and Puducherry. Following the deaths of 12 children in Madhya Pradesh and Rajasthan, the Tamil Nadu government has banned the sale of the cough syrup "Coldrif."
Rajasthan Government Action
The Rajasthan government has also taken action regarding the "Coldrif" cough syrup. Taking action, the Rajasthan government has suspended the drug controller and halted the distribution of medicines manufactured by the Jaipur-based company, Kesons Pharma. Officials stated that the Medical and Health Department has banned the supply of all 19 medicines manufactured by Kesons Pharma until further notice. The distribution of all other cough syrups containing dextromethorphan has been suspended.
Health Ministry Issues Directive
Taking cognizance of the child deaths, the Union Health Ministry on Friday issued directives to all states and union territories, stating that cough and cold medicines should not be given to children under the age of two. This directive, issued by the Directorate General of Health Services, comes amid the deaths of children in Madhya Pradesh and Rajasthan from allegedly contaminated cough syrup.
Allegations of Addition of Brake Oil Solvent to Cough Syrup
Senior Madhya Pradesh Congress leader Kamal Nath has blamed the addition of 'brake oil solvent' to cough syrup for the deaths of children suffering from suspected kidney disease in Chhindwara district since September 7. Meanwhile, the Health Ministry has ordered the company to halt production of the syrup at its facility until laboratory reports are received.
India’s digital payment ecosystem has transformed rapidly over the past few years, with UPI
The changing weather in Delhi over the past few days has brought a mild winter. People have exper
Apple has reclaimed the title of the world's most valuable publicly traded company, overtaking AI
Sunrisers Hyderabad secured a 65-run victory over Kolkata Knight Riders, thereby opening their wi
Zerodha founder Nithin Kamath has shared a powerful message on success, entrepreneurship and Indi
The Thackeray brothers have surprised everyone with a major decision in Maharashtra politics. Udd
Indian team star batsman Rohit Sharma appeared in public for the first time since being removed f
SBI Funds Management IPO Opens Today: 3 Brokerages Recommend 'Subscribe'; Check Latest GMP
The ₹9,813 crore SBI Funds Management IPO, one of the biggest public issues in India's asset ma
The Cannes Film Festival is currently underway. Amidst the festivities, a 4K restored version of
A new twist has emerged in the case involving allegations of intimate harassment and forced relig
